Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22853847 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
Condition: Hypertension
Interventions: Drug: irbesartan/amlodipine;   Drug: irbesartan

Indicates status has not been verified in more than two years